NCT00990886View on ClinicalTrials.gov

The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women

PHASE2CompletedINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

MenopauseHot Flashes

Interventions

DRUG

Placebo

Once daily for 12 weeks

DRUG

Oxybutynin chloride

15 mg once daily for 12 weeks

All Listed Sponsors

lead

Ortho-McNeil Janssen Scientific Affairs, LLC

INDUSTRY

NCT00990886 - The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women | Biotech Hunter | Biotech Hunter